Profile | GDS4284 / 206275_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 79.0681 | 32 |
GSM687648 | Patient 402 control | 130.548 | 41 |
GSM687653 | Patient 403 control | 112.207 | 38 |
GSM687658 | Patient 404 control | 174.109 | 46 |
GSM687663 | Patient 411 control | 40.3831 | 19 |
GSM687668 | Patient 422 control | 198.076 | 49 |
GSM687673 | Patient 424 control | 246.355 | 51 |
GSM687678 | Patient 425 control | 127.633 | 38 |
GSM687683 | Patient 427 control | 166.04 | 42 |
GSM687688 | Patient 428 control | 147.892 | 42 |
GSM687695 | Patient 441 control | 574.159 | 64 |
GSM687699 | Patient 443 control | 308.257 | 54 |
GSM687704 | Patient 444 control | 38.4184 | 20 |
GSM687707 | Patient 448 control | 125.637 | 34 |
GSM687712 | Patient 449 control | 175.322 | 45 |
GSM687719 | Patient 450 control | 198.104 | 44 |
GSM687724 | Patient 451 control | 196.136 | 45 |
GSM687728 | Patient 452 control | 138.535 | 39 |
GSM687646 | Patient 401 treated 24h | 114.924 | 37 |
GSM687649 | Patient 402 treated 24h | 95.8937 | 36 |
GSM687665 | Patient 411 treated 24h | 123.981 | 36 |
GSM687651 | Patient 402 treated 4 weeks | 226.494 | 50 |
GSM687667 | Patient 411 treated 4 weeks | 214.951 | 49 |
GSM687670 | Patient 422 treated 24h | 139.455 | 40 |
GSM687671 | Patient 422 treated 4 weeks | 137.652 | 42 |
GSM687654 | Patient 403 treated 24h | 124.086 | 41 |
GSM687675 | Patient 424 treated 24h | 225.475 | 49 |
GSM687685 | Patient 427 treated 24h | 183.926 | 46 |
GSM687656 | Patient 403 treated 4 weeks | 29.6876 | 18 |
GSM687677 | Patient 424 treated 4 weeks | 175.256 | 46 |
GSM687687 | Patient 427 treated 4 weeks | 43.386 | 23 |
GSM687692 | Patient 428 treated 4h | 59.7461 | 25 |
GSM687716 | Patient 449 treated 4h | 71.7979 | 28 |
GSM687722 | Patient 450 treated 4h | 103.628 | 32 |
GSM687680 | Patient 425 treated 24h | 183.894 | 47 |
GSM687690 | Patient 428 treated 24h | 157.657 | 45 |
GSM687700 | Patient 443 treated 24h | 419.733 | 57 |
GSM687705 | Patient 444 treated 24h | 18.3977 | 11 |
GSM687714 | Patient 449 treated 24h | 71.0285 | 30 |
GSM687721 | Patient 450 treated 24h | 324.355 | 54 |
GSM687682 | Patient 425 treated 4 weeks | 75.3044 | 30 |
GSM687694 | Patient 428 treated 4 weeks | 103.035 | 37 |
GSM687702 | Patient 443 treated 4 weeks | 192.033 | 45 |
GSM687718 | Patient 449 treated 4 weeks | 17.2597 | 10 |
GSM687723 | Patient 450 treated 4 weeks | 54.1999 | 23 |
GSM687661 | Patient 404 treated 4h | 41.8302 | 20 |
GSM687710 | Patient 448 treated 4h | 69.0491 | 28 |
GSM687726 | Patient 451 treated 4h | 246.461 | 50 |
GSM687730 | Patient 452 treated 4h | 60.1126 | 14 |
GSM687660 | Patient 404 treated 24h | 294.135 | 53 |
GSM687697 | Patient 441 treated 24h | 486.748 | 61 |
GSM687709 | Patient 448 treated 24h | 148.405 | 40 |
GSM687725 | Patient 451 treated 24h | 221.49 | 47 |
GSM687729 | Patient 452 treated 24h | 475.872 | 62 |
GSM687727 | Patient 451 treated 4 weeks | 135.743 | 36 |
GSM687731 | Patient 452 treated 4 weeks | 119.249 | 35 |